Experience

Vera Therapeutics, Inc.

• United States
• Biotechnology
• 1 - 100 Employee

• Chief Financial Officer at Vera Therapeutics, Inc.

  • Jul 2021 - Present



CareDx, Inc.

• United States
• Biotechnology Research
• 400 - 500 Employee

• Vice President, Corporate Strategy & Business Development

  • May 2020 - Jul 2021

  South San Francisco, California, United States Lead strategic planning and execution for M&A, venture investments and partnerships.



Citi

• United States
• Financial Services
• 700 & Above Employee

• Vice President, Healthcare Investment Banking

  • Jul 2015 - Mar 2020

  Served as Vice President in the Investment Banking Healthcare Division at Citigroup Global Capital Markets. Transactions led as bookrunner or advisor: - Gilead acquisition of Forty Seven $4.9bn - Eiger follow-on equity offering $57mm - CymaBay follow-on equity offering $115mm - Tocagen follow-on equity offering $30mm - Tocagen ATM offering $30mm - Coherus follow-on equity offering $86mm - Calyxt follow-on equity offering $61mm - Cellectis follow-on equity… Show more Served as Vice President in the Investment Banking Healthcare Division at Citigroup Global Capital Markets. Transactions led as bookrunner or advisor: - Gilead acquisition of Forty Seven $4.9bn - Eiger follow-on equity offering $57mm - CymaBay follow-on equity offering $115mm - Tocagen follow-on equity offering $30mm - Tocagen ATM offering $30mm - Coherus follow-on equity offering $86mm - Calyxt follow-on equity offering $61mm - Cellectis follow-on equity offering $191mm - Calyxt carve-out initial public offering $64mm - Coherus follow-on equity offering $128mm - Tobira Therapeutics sale to Allergan $1.7bn - CRISPR Therapeutics initial public offering $62mm - Kite Pharma follow-on equity offering $288mm Show less



NaviMed Capital

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Spring Associate

  • Feb 2015 - May 2015

  NaviMed Capital is a healthcare focused growth capital firm based in Washington, DC. NaviMed focuses on investing in revenue-generating, commercial-stage companies in Health IT, Health Services, and Medical Products.



Piper Jaffray

• United States
• Financial Services
• 300 - 400 Employee

• Investment Banking Summer Associate

  • May 2014 - Aug 2014

  Charlotte, North Carolina Area Executed M&A transactions and provided strategic advisory services for middle market companies.



Grant Consulting Group

• United States
• Government Relations Services
• 1 - 100 Employee

• Vice President

  • Aug 2010 - May 2014

  Washington D.C. Metro Area Provided clients with strategy guidance informed by in-depth experience developing and implementing accelerated growth strategies for domestic and international clients from Fortune 100 companies to startups in the financial services, defense, technology, education, health, and public safety industries.



ESI Group

• France
• Software Development
• 700 & Above Employee

• Manager, Business Development for Nuclear Power

  • May 2009 - Aug 2010

  Managed business development and sales in North America for ESI a world leading software editor for the numerical simulation of prototype and manufacturing process engineering in applied mechanics.



National Association of Manufacturers - NAM

• United States
• Government Relations Services
• 200 - 300 Employee

• Legislative Analyst

  • Jun 2007 - May 2009

  Contributed to the development of NAM policy related to federal legislative and regulatory matters, as well as communications, government relations and advocacy efforts in Washington, D.C. and around the country to advance the NAM agenda for jobs and economic growth in America for its 11,000 member companies.